Evidence map›Paper›PMID 38268531›Full record

ReviewJournal of immunology research2024

Blocking Superantigen-Mediated Diseases: Challenges and Future Trends.

Pengbo Wang, Zina Fredj, Hongyong Zhang, Guoguang Rong, Sumin Bian, Mohamad Sawan

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of immunology research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pengbo WangCenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.ORCID https://orcid.org/0000-0002-4603-2572
Zina FredjCenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.ORCID https://orcid.org/0000-0003-4265-2990
Hongyong ZhangCenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.
Guoguang RongCenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.
Sumin BianCenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.ORCID https://orcid.org/0000-0002-9470-8143
Mohamad SawanCenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.ORCID https://orcid.org/0000-0002-4137-7272
Westlake University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superantigens are virulence factors secreted by microorganisms that can cause various immune diseases, such as overactivating the immune system, resulting in cytokine storms, rheumatoid arthritis, and multiple sclerosis. Some studies have demonstrated that superantigens do not require intracellular processing and instated bind as intact proteins to the antigen-binding groove of major histocompatibility complex II on antigen-presenting cells, resulting in the activation of T cells with different T-cell receptor V

Indexed as

AntibodiesCD28 AntigensAntigen-Presenting CellsPeptidesSuperantigensAntibodiesCD28 AntigensPeptidesSuperantigens

Identifiers

PMID38268531
PMCPMC10807946
OpenAlexW4390937197

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.